Unintended HIV-1 Infection During Analytical Therapy Interruption

被引：28
|
作者：
Ugarte, Ainoa [1 ]
Romero, Yolanda [1 ]
Tricas, Amparo [1 ]
Casado, Concepcion [2 ]
Lopez-Galindez, Cecilio [2 ]
Garcia, Felipe [1 ,3 ]
Leal, Lorna [1 ,3 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Infect Dis HIV Unit, Barcelona, Spain
[2] Inst Salud Carlos III, Mol Virol Unit, Natl Ctr Inst Salud Carlos III, Madrid, Spain
[3] Inst Invest Biomed August Pi Sunyer IDIBAP, AIDS Res Grp, HIVACAT HIV Vaccine Dev Program, Barcelona, Spain
来源：
JOURNAL OF INFECTIOUS DISEASES | 2020年 / 221卷 / 10期
关键词：
D O I：
10.1093/infdis/jiz611
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1740 / 1742
页数：3
相关论文
共 50 条
  • [1] Kinetics of plasma cytokines and chemokines during primary HIV-1 infection and after analytical treatment interruption
    Barqasho, B.
    Nowak, P.
    Tjernlund, A.
    Kinloch, S.
    Goh, L-E
    Lampe, F.
    Fisher, M.
    Andersson, J.
    Sonnerborg, A.
    HIV MEDICINE, 2009, 10 (02) : 94 - 102
  • [2] Randomized, controlled trial of therapy interruption in chronic HIV-1 infection
    Papasavvas, E
    Kostman, JR
    Mounzer, K
    Grant, RM
    Gross, R
    Gallo, C
    Azzoni, L
    Foulkes, A
    Thiel, B
    Pistilli, M
    Mackiewicz, A
    Shull, J
    Montaner, LJ
    PLOS MEDICINE, 2004, 1 (03) : 218 - 228
  • [3] Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
    Ventura, John D.
    Beloor, Jagadish
    Allen, Edward
    Zhang, Tongyu
    Haugh, Kelsey A.
    Uchil, Pradeep D.
    Ochsenbauer, Christina
    Kieffer, Collin
    Kumar, Priti
    Hope, Thomas J.
    Mothes, Walther
    PLOS PATHOGENS, 2019, 15 (12)
  • [4] Cognitive safety of interruption of HAART in HIV-1 infection
    Childers, ME
    Woods, SP
    Letendre, S
    Mindt, MR
    McCutchan, JA
    Ellis, RJ
    NEUROLOGY, 2004, 62 (07) : A408 - A408
  • [5] Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infection
    Burton, CT
    Nelson, MR
    Hay, P
    Gazzard, BG
    Gotch, FM
    Imami, N
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (02): : 354 - 361
  • [6] A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
    Kroon, Eugene D. M. D.
    Ananworanich, Jintanat
    Pagliuzza, Amelie
    Rhodes, Ajantha
    Phanuphak, Nittaya
    Trautmann, Lydie
    Mitchell, Julie L.
    Chintanaphol, Michelle
    Intasan, Jintana
    Pinyakorn, Suteeraporn
    Benjapornpong, Khuntalee
    Chang, J. Judy
    Colby, Donn J.
    Chomchey, Nitiya
    Fletcher, James L. K.
    Eubanks, Keith
    Yang, Hua
    Kapson, John
    Dantanarayana, Ashanti
    Tennakoon, Surekha
    Gorelick, Robert J.
    Maldarelli, Frank
    Robb, Merlin L.
    Kim, Jerome H.
    Spudich, Serena
    Chomont, Nicolas
    Phanuphak, Praphan
    Lewin, Sharon R.
    de Souza, Mark S.
    JOURNAL OF VIRUS ERADICATION, 2020, 6 (03)
  • [7] THERAPY OF HIV-1 INFECTION
    KOZAL, MJ
    MERIGAN, TC
    CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (01) : 72 - 81
  • [8] Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
    Paci, Paola
    Carello, Rossella
    Bernaschi, Massimo
    D'Offizi, Gianpiero
    Castiglione, Filippo
    BMC INFECTIOUS DISEASES, 2009, 9 : 172
  • [9] Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
    Paola Paci
    Rossella Carello
    Massimo Bernaschi
    Gianpiero D'Offizi
    Filippo Castiglione
    BMC Infectious Diseases, 9
  • [10] Treatment interruption in chronic HIV-1 infection: does it deliver?
    Willberg, Christian B.
    Nixon, Douglas F.
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (01) : 26 - 30
12345